Can Synthesis Impurities in Calcitonin Peptide Drugs Trigger Immune Reactions?
Some impurities generated during salmon calcitonin peptide synthesis showed potential to bind immune molecules and stimulate T cells, posing immunogenicity risk.
Quick Facts
What This Study Found
Certain synthesis-derived impurities of salmon calcitonin showed potential to bind HLA molecules and stimulate T cells, indicating immunogenicity risk that warrants monitoring.
Key Numbers
Impurities included amino acid insertions, deletions, and side-chain modifications from the synthesis process.
How They Did This
Combined computational (in silico) prediction with in vitro HLA binding and T-cell stimulation assays to assess immunogenicity of peptide impurities.
Why This Research Matters
As more peptide drugs shift from biological to chemical manufacturing, understanding whether new impurities can trigger immune reactions is essential for drug safety.
The Bigger Picture
More peptide drugs are being manufactured by chemical synthesis instead of biological production. Understanding the immunogenicity risk of synthesis-related impurities is essential for ensuring generic and biosimilar peptide drug safety.
What This Study Doesn't Tell Us
In silico and in vitro methods can predict immunogenicity risk but cannot confirm actual clinical immune reactions. In vivo validation would be needed.
Questions This Raises
- ?Should immunogenicity testing be mandatory for all chemically synthesized peptide drugs?
- ?Do these impurities accumulate at clinically relevant levels?
Trust & Context
- Key Stat:
- T-cell stimulation detected Certain synthesis byproducts of salmon calcitonin showed the ability to activate immune T cells in laboratory assays
- Evidence Grade:
- Rated preliminary: combined computational and in vitro assessment identifying risk, but clinical significance needs in vivo confirmation.
- Study Age:
- Published in 2024. Timely as more peptide drugs (especially GLP-1 drugs) shift to chemical synthesis manufacturing.
- Original Title:
- Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods.
- Published In:
- Frontiers in pharmacology, 15, 1363139 (2024)
- Authors:
- Roberts, Brian J, Mattei, Aimee E, Howard, Kristina E, Weaver, James L, Liu, Hao, Lelias, Sandra, Martin, William D, Verthelyi, Daniela, Pang, Eric, Edwards, Katie J, De Groot, Anne S
- Database ID:
- RPEP-09158
Evidence Hierarchy
Frequently Asked Questions
What are peptide drug impurities?
Manufacturing byproducts where amino acids are inserted, deleted, or modified, creating slightly different molecules from the intended drug.
Can impurities in peptide drugs cause allergic reactions?
This study shows some impurities can potentially activate immune cells. Whether this translates to clinical reactions needs further investigation.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09158APA
Roberts, Brian J; Mattei, Aimee E; Howard, Kristina E; Weaver, James L; Liu, Hao; Lelias, Sandra; Martin, William D; Verthelyi, Daniela; Pang, Eric; Edwards, Katie J; De Groot, Anne S. (2024). Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods.. Frontiers in pharmacology, 15, 1363139. https://doi.org/10.3389/fphar.2024.1363139
MLA
Roberts, Brian J, et al. "Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods.." Frontiers in pharmacology, 2024. https://doi.org/10.3389/fphar.2024.1363139
RethinkPeptides
RethinkPeptides Research Database. "Assessing the immunogenicity risk of salmon calcitonin pepti..." RPEP-09158. Retrieved from https://rethinkpeptides.com/research/roberts-2024-assessing-the-immunogenicity-risk
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.